|Day Low/High||7.50 / 8.14|
|52 Wk Low/High||1.03 / 9.40|
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
We have a few more days of this slow trading, and it is unlikely to change much.
Signs of support on the S&P, but there is a lot of uncertainty.
But bears finally have some momentum heading into a seasonally poor month.
Lexicon Pharmaceuticals (LXRX) shares are up nearly 50% since it announced Monday that its carcinoid syndrome drug telotristat etiprate met its primary endpoint in a late stage clinical trial.